This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by examining how and why social determinants differentially impact health, healthcare, and health outcomes.
Elsevier,
Clinical Decision Support for Pharmacogenomic Precision Medicine: Foundations and Implementation, 2022, Pages 85-106
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by bringing attention to the inequity in access to pharmacogenomic implementation efforts and how CDS can address this issues.
A Health Policy paper on the health impacts of banned pesticides in the Yaqui population in Mexico, in the context of SDGs 3, 10, and 12, highlighting recommendations for system-level solutions and policy change to current US, UN, and global laws.
This content aligns with Goal 10: Reduced Inequalities by exploring the ways in which LCCs make possible a new generation of air traveler that previously did not have access to aeromobility. It discusses how the expansion of low-cost carriers in a region of marked socioeconomic inequality unsettles the privileged origins of flying as a means of transport, complicates the mundane position of flying as a form of mobility, and brings to the surface questions of identity, class, and race among the flying public.
Racial and Ethnic discrimination effects on adolescent mental health.
This Article supports SDGs 3, 5, and 10 focusing on the religious and cultural aspects that influence Arab American women's perspectives on health-care in the USA.
Meaningful engagement and tailored information can support effective vaccine promotion. Organisational level change is needed to address structural barriers, inequities, and discrimination.
Providing affordable access to enough healthy and safe food for an ever-more-affluent and growing world population has become more challenging in the face of climate change, rising income inequality a
Elsevier,
Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 147-164
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing the most recent scientific advances that have improved diagnostic abilities and showcasing experimental studies of gene therapy and conventional pharmacological treatments to lead to effective treatment of these hereditary disorders.
